Metaflammation - TOWARDS LIFE-KNOWLEDGE

Chronic metabolic diseases are widely understood as disorders of excess — excess calories, excess adiposity, excess glucose, excess inflammation. However, converging evidence across mitochondrial biology, adipose immunology, hepatic lipid metabolism, autonomic physiology, microbiome signaling, and circadian regulation indicates that the primary pathology is not excess activation, but impaired resolution.

Metabolic health depends on the capacity to transition between energetic states — to shift flexibly between glucose and lipid utilization, sympathetic activation and parasympathetic recovery, inflammatory initiation and resolution. This capacity for state-transition is governed by an integrated network linking mitochondrial dynamics, adipose endocrine signaling, immune tone, vagal modulation, and circadian control. When these systems become synchronized in rigidity, metaflammation, adipose overflow, mitochondrial fragmentation, and autonomic threat-lock emerge, forming the shared mechanistic substrate of diabetes, hypertension, NAFLD, cardiovascular disease, autoimmune vulnerability, and neurodegeneration.

This work presents a unified, physiology-first framework for understanding the onset, progression, and potential reversibility of chronic disease. It clarifies how recovery occurs when the conditions for resolution are restored — not through intensification, restriction, or control, but through re-enabling the organism’s innate capacity to return to repair.

Chronic non-communicable diseases (NCDs) such as cardiovascular disease, diabetes, cancer, dementia, and depression now account for nearly three-quarters of global deaths. Traditionally, these diseases have been framed as the inevitable outcomes of biological aging, genetics, and individual “lifestyle choices.” This white paper challenges that paradigm, demonstrating that the so-called “natural history” of these diseases is, in fact, largely anthropogenic — shaped by human-designed systems, policies, and environments.

Upstream determinants — including food systems, housing quality, advertising landscapes, workplace structures, and environmental exposures — create exposure fields that drive disruptions in a small set of shared biological pathways: metaflammation, insulin resistance, endothelial injury, circadian misalignment, and microbiome disruption. These pathways explain why single exposures influence multiple diseases simultaneously, and why population health cannot be restored by downstream treatments alone.

Recognizing the designable nature of disease trajectories reframes prevention, accountability, and equity. Human-made causes imply human-reversible solutions: redesigning upstream determinants through policy, regulation, and systemic advocacy can bend population risk curves earlier, faster, and more equitably than reactive healthcare ever could.

This reframing calls for a paradigm shift in medicine, public health, and governance. Clinicians must integrate determinant histories and dual-lever treatment plans. Policymakers must deploy high-leverage interventions such as regulating harmful advertising, incentivizing nutrient-rich food systems, and redesigning urban spaces. Communities must be empowered to co-create healthier defaults. Together, these strategies represent a collective opportunity to reimagine health as a design challenge — one where prevention by design becomes the foundation for population flourishing.